Recalls & Warnings April 10, 2021 Companies Deceived Consumers About Fish Oil for Liver Disease, Says FTC On April 1, 2021, the Federal Trade Commission (FTC) announced that fish oil supplement manufacturer BASF SE and its U.S
Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2
Can patients in New York access BPC-157 through telehealth
In these cases, a 3 ml syringe is appropriate to accommodate the higher volume
B12 shots are administered either intramuscularly (into the muscle) or subcutaneously (just under the skin)
&srotate=0)
